Zdrowie i gospodarka · 14.08.2014
Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs; Reopening of the Comment Period
The Food and Drug Administration (FDA) is reopening the comment period for the draft guidance entitled "Best Practices in Developing Proprietary Names for Drugs," which published in the Federal Register of May 29, 2014 (79 FR 30852). FDA is reopening the comment period in response to several requests for additional time and to allow interested persons more time to submit comments.